Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Immersive virtual reality to reduce breathing effort during exercise in healthy adults

Official title: Impact of Immersive Virtual Reality (IVR) on Respiratory Effort: A Pilot Study in Healthy Adults

Run by Pontificia Universidad Catolica de Chile · NCT07498816 · Data updated 2026-11-12

This study will test whether immersive virtual reality during a 6-minute moderate cycling session can reduce how hard breathing feels in healthy adults aged 18–40.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment10 (estimated)
SponsorPontificia Universidad Catolica de Chile
Academic / other
Locations1 site (Santiago, Santiago Metropolitan)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedMarch 20, 2026
Study endsDecember 15, 2026
Registry record updatedMarch 27, 2026
Trial IDNCT07498816 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–40 who can perform cycle ergometer testing, tolerate an esophageal balloon catheter, are not pregnant, and have no known cardiovascular, pulmonary, neurological, or metabolic disease and are not prone to motion sickness.

Probably not a fit

People with existing cardiopulmonary or neurological disease, those who cannot tolerate IVR or an esophageal catheter, pregnant individuals, or those taking medications that affect respiratory or cardiovascular responses are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized crossover pilot where healthy adults complete two exercise sessions: one with immersive virtual reality (IVR) and one without, in randomized order. In both sessions participants perform a 6-minute constant-load cycling test at a submaximal workload individualized from a prior incremental exercise test. Respiratory effort is measured continuously using esophageal pressure monitoring, with additional recordings of ventilatory variables, perceived dyspnea, acute state anxiety, and heart rate. The single-site protocol is conducted at Pontificia Universidad Católica de Chile and is designed to detect acute IVR effects on physiological and perceptual responses to exercise.

Why it matters

Potential benefit: If successful, IVR could offer a nonpharmacologic way to lessen perceived breathing effort during exertion and help guide symptom-relief strategies for people with exertional dyspnea.

How similar studies have gone: Previous IVR studies have reduced anxiety, pain, and stress and have modulated physiological responses, but direct evidence that IVR lowers respiratory effort during exercise is currently lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy adults aged 18-40 years
* Ability to perform cycle ergometer exercise testing
* No known history of cardiovascular, pulmonary, neurological, or metabolic disease

Exclusion Criteria:

* Current respiratory symptoms or acute illness
* Known cardiovascular, pulmonary, neurological, or metabolic disease
* Use of medications that may affect respiratory or cardiovascular responses to exercise
* Contraindications to exercise testing according to standard clinical guidelines
* Pregnancy
* Inability to tolerate placement of an esophageal balloon catheter
* Susceptibility to motion sickness or discomfort with immersive virtual reality devices

Where it's running

  • Escuela de Ciencias de la Salud UC. Departamento de Kinesiología.
    Santiago, Santiago Metropolitan, Chile
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.